(주)전진바이오: 손익 계산서 (TTM)

(주)전진바이오
KR ˙ KOSDAQ
₩1,901.00 ↓ -73.00 (-3.70%)
2026-06-05
주가
손익 계산서 (TTM)

(주)전진바이오 손익 계산서(Income Statement)에는 일정 기간 동안의 소득 및 지출 변화가 표시됩니다. 손익 계산서 데이터에는 판매액(Sales), 매출액(Revenue), 총이익(Gross Profit), 연구개발(R&D), 판매 및 관리비(SG&A: Selling, General and Administrative Expense), 영업이익(Operating Income), 소득세 비용, 이자 비용, 비영업이익, 주당이익(EPS: Earnings per Share) 및 발행 주식수로 구성됩니다.

모든 수치는 지분 단위당 1,000,000 제외의 곱입니다.123456

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
수익 3,796 3,496 3,214 3,457 4,557 5,899 7,794 9,055 10,893 13,204 15,681 17,686 19,142 19,959 19,273 17,022 15,451 14,654 13,694 14,421
변화 (%) -7.91 -8.05 7.55 31.82 29.45 32.12 16.18 20.30 21.22 18.75 12.79 8.23 4.27 -3.44 -11.68 -9.23 -5.16 -6.55 5.31
수익의 % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
매출원가 1,994 1,849 1,898 2,470 3,489 4,638 5,836 6,659 7,727 9,228 10,861 12,004 13,033 13,450 13,271 12,088 10,984 10,598 9,952 10,451
변화 (%) -7.29 2.69 30.10 41.28 32.93 25.82 14.10 16.05 19.42 17.70 10.53 8.57 3.20 -1.33 -8.91 -9.14 -3.52 -6.09 5.01
수익의 % 52.53 52.88 59.06 71.44 76.56 78.63 74.87 73.54 70.94 69.89 69.26 67.87 68.09 67.39 68.86 71.02 71.09 72.32 72.68 72.47
총 영업 이익 1,802 1,647 1,316 987 1,068 1,261 1,958 2,396 3,166 3,976 4,820 5,682 6,108 6,509 6,002 4,933 4,467 4,056 3,742 3,970
변화 (%) -8.59 -20.10 -24.98 8.17 18.06 55.31 22.37 32.10 25.61 21.21 17.89 7.51 6.56 -7.80 -17.80 -9.44 -9.21 -7.74 6.10
수익의 % 47.47 47.12 40.94 28.56 23.44 21.37 25.13 26.46 29.06 30.11 30.74 32.13 31.91 32.61 31.14 28.98 28.91 27.68 27.32 27.53
판매관리비 3,698 3,793 3,716 3,328 3,374 3,384 3,373 3,560 3,753 3,914 3,937 3,841 3,792 3,572 3,359 3,218 3,034 3,040 3,426 3,385
변화 (%) 2.56 -2.01 -10.44 1.37 0.30 -0.31 5.53 5.44 4.29 0.57 -2.43 -1.28 -5.81 -5.95 -4.20 -5.71 0.17 12.72 -1.20
수익의 % 97.42 108.49 115.61 96.28 74.03 57.36 43.28 39.31 34.46 29.65 25.11 21.72 19.81 17.89 17.43 18.91 19.64 20.74 25.02 23.48
연구개발 352 375 364 411 371 399 422 405 425 419 448 455 430 395 362 370 399 429 438 422
변화 (%) 6.47 -2.98 12.88 -9.69 7.70 5.64 -4.13 5.00 -1.35 6.85 1.56 -5.53 -8.08 -8.39 2.42 7.79 7.35 2.18 -3.56
수익의 % 9.28 10.73 11.32 11.88 8.14 6.77 5.41 4.47 3.90 3.17 2.86 2.57 2.24 1.98 1.88 2.18 2.58 2.93 3.20 2.93
운영 비용 6,325 6,282 6,244 6,491 7,812 9,304 10,930 12,248 13,586 15,298 16,925 17,957 18,770 18,832 18,115 16,459 14,979 14,358 14,037 14,487
변화 (%) -0.68 -0.60 3.95 20.35 19.11 17.47 12.06 10.92 12.60 10.64 6.09 4.53 0.33 -3.81 -9.14 -8.99 -4.15 -2.23 3.20
수익의 % 166.62 179.70 194.26 187.76 171.42 157.72 140.23 135.27 124.72 115.86 107.94 101.53 98.06 94.35 93.99 96.70 96.94 97.98 102.50 100.45
영업 이익 -2,529 -2,786 -3,030 -3,034 -3,255 -3,405 -3,136 -3,193 -2,693 -2,094 -1,245 -270 372 1,127 1,158 562 472 295 -343 -66
변화 (%) 10.18 8.74 0.14 7.27 4.63 -7.91 1.83 -15.67 -22.25 -40.54 -78.29 -237.46 203.45 2.73 -51.44 -16.05 -37.42 -216.03 -80.87
수익의 % -66.62 -79.70 -94.26 -87.76 -71.42 -57.72 -40.23 -35.27 -24.72 -15.86 -7.94 -1.53 1.94 5.65 6.01 3.30 3.06 2.02 -2.50 -0.45
이자 비용 -534 -652 -866 -1,252 -1,890 -2,017 -2,035 -1,948 -1,507 -1,511 -1,195 -1,007 -870 -496 -432 -190 -10 -4 -0 0
변화 (%) 22.15 32.83 44.61 51.01 6.69 0.89 -4.27 -22.65 0.28 -20.90 -15.72 -13.67 -42.93 -12.90 -56.08 -94.76 -64.69 -90.73 -100.00
수익의 % -14.06 -18.64 -26.93 -36.21 -41.48 -34.19 -26.11 -21.51 -13.83 -11.44 -7.62 -5.70 -4.54 -2.49 -2.24 -1.12 -0.06 -0.02 -0.00 0.00
당기순이익 -3,275 -3,609 -2,108 -2,462 -2,228 -2,504 -3,113 -2,999 -4,905 -4,327 -6,440 -5,550 -201 978 4,346 4,245 956 728 -196 17
변화 (%) 10.20 -41.59 16.76 -9.48 12.39 24.32 -3.65 63.54 -11.79 48.84 -13.82 -96.38 -586.26 344.54 -2.33 -77.47 -23.86 -126.89 -108.50
수익의 % -86.28 -103.25 -65.59 -71.20 -48.89 -42.45 -39.94 -33.12 -45.03 -32.77 -41.07 -31.38 -1.05 4.90 22.55 24.94 6.19 4.97 -1.43 0.12

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista